A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases

Author： Pandey Saumya   Srivastava Satish K   Ramana Kota V  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.3, 2012-03, pp. : 329-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of aldose reductase inhibitors for the treatment of inflammatory disorders

By Chatzopoulou Maria   Pegklidou Kyriaki   Papastavrou Nikolaos   Demopoulos Vassilis J  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1365-1380

Informa Healthcare

Access to resources Recommend Favorite

Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders

By Inoue Ken-ichiro   Takano Hirohisa  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 513-520

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

By Miyamoto Shuichi  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 621-631

Informa Healthcare

Access to resources Recommend Favorite

Aldose reductase inhibitors: therapeutic implications for diabetic complications

By Oates P.J.   Mylari B.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2095-2119

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 282-287

Bentham Science Publishers

Access to resources Recommend Favorite